Target intelligence / Profile preview

Multiple Molecular Pathways for Neuroprotection and Anti-inflammation

Molecular classification
Other (multiple pathways affected, including transcription factors and signaling proteins such as NF-κB, cytokines, and enzymes)
01

Overview

This entry refers to multiple signaling and molecular pathways involved in neuroprotection and anti-inflammatory responses targeted by herbal constituents, particularly resveratrol glycosides found in Polygonum cuspidatum. Unlike defined drug targets (such as specific receptors or enzymes), these pathways encompass transcription factors (e.g., NF-κB), inflammatory cytokines (TNF-α, IL-6), and related signal transduction processes. The lack of a standardized or canonical molecular target means this is not considered a true therapeutic target by Western pharmacological standards. Instead, these herbal components act pleiotropically, influencing diverse biological functions such as immune modulation, cell survival, oxidative stress defenses, and inflammation reduction. Clinical and biochemical studies demonstrate effects on biomarkers like TNF-α and IL-6, with bioavailability and metabolic stability presenting therapeutic challenges. The absence of a single, well-defined molecule or receptor renders this entry non-canonical as a pharmacological target.

Other names
Polygonum cuspidatum active constituentsresveratrol glycosidespolydatinemodinmulti-target pathways
02

Mechanism of action

The mechanism of action involves the modulation of the NF-κB signaling pathway, inhibition of inflammatory cytokines (e.g., TNF-α, IL-6), suppression of oxidative stress, and regulation of transcription factors and signal transduction cascades.

03

Biological functions

NeuroprotectionAnti-inflammatory responseAntioxidant activityModulation of cell signalingRegulation of cytokine production
04

Disease associations

InflammationNeurodegenerative disease (protective effects proposed, not target-specific)Cancer (antitumor activity attributed to components, not standardized target)Cardiovascular diseaseOther (e.g., colitis, arthritis, diabetes complications, retinopathy)
05

Safety considerations

Low oral bioavailability of resveratrol and derivativesStability and rapid metabolism of active constituentsLack of clinical evidence for disease modification or specific target engagement
06

Interacting drugs

Dietary supplements containing Polygonum cuspidatum extract, resveratrol, polydatin, and emodin
07

Biomarkers

Plasma levels of TNF-αInterleukin-6 (IL-6)Other inflammatory cytokines

Beyond the preview

Go deeper on Multiple Molecular Pathways for Neuroprotection and Anti-inflammation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple Molecular Pathways for Neuroprotection and Anti-inflammation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call